IL6 and systemic lupus erythematosus: Of interest, pathways associated with systemic lupus erythematosus (SLE), Th1 responses, IL-6 signaling, and neuroinflammation were among those pathways increased in AMS SLCLs compared to HC SLCLs (Fig. 5C).